Horizon Kinetics’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$563K Hold
9,000
0.02% 231
2018
Q3
$695K Hold
9,000
0.02% 228
2018
Q2
$638K Hold
9,000
0.02% 236
2018
Q1
$679K Sell
9,000
-400
-4% -$31.8K 0.02% 230
2017
Q4
$674K Hold
9,400
0.02% 236
2017
Q3
$761K Hold
9,400
0.02% 220
2017
Q2
$665K Sell
9,400
-4,200
-31% -$279K 0.02% 247
2017
Q1
$923K Buy
13,600
+600
+5% +$42.2K 0.03% 202
2016
Q4
$930K Buy
13,000
+1,450
+13% +$108K 0.03% 198
2016
Q3
$914K Buy
11,550
+1,500
+15% +$122K 0.03% 211
2016
Q2
$839K Buy
10,050
+50
+0.5% +$4.44K 0.02% 229
2016
Q1
$919K Hold
10,000
0.02% 209
2015
Q4
$1.01M Buy
10,000
+50
+0.5% +$5.2K 0.02% 194
2015
Q3
$977K Buy
9,950
+1,000
+11% +$111K 0.02% 199
2015
Q2
$1.05M Buy
8,950
+250
+3% +$27.3K 0.02% 227
2015
Q1
$854K Buy
+8,700
New +$883K 0.01% 295

Other funds holding GILD

Horizon Kinetics's GILD Position: Q4 2018 in Review

Horizon Kinetics held its Gilead Sciences (GILD) position steady in Q4 2018 at 9,000 shares worth $563K. The position accounts for 0.02% of the portfolio, ranked #231.

Horizon Kinetics first reported a position in GILD in Q1 2015 and has held it in 16 quarters since. The position peaked at $1.05M in Q2 2015. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Horizon Kinetics held 9,000 shares of Gilead Sciences worth $563K as of Q4 2018.
  • Horizon Kinetics left its Gilead Sciences share count unchanged in Q4 2018.
  • Gilead Sciences made up 0.02% of Horizon Kinetics's portfolio in Q4 2018, its #231 holding.
  • Horizon Kinetics first reported a position in Gilead Sciences in Q1 2015 and has held it in 16 quarters since.
  • Horizon Kinetics's Gilead Sciences position peaked at $1.05M in Q2 2015.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.